Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma. | Am J Clin Pathol | 2025 | 40327767 | PubTator, text mining | PubMed |
| Datopotamab Deruxtecan: First Approval. | Drugs | 2025 | 40323341 | PubTator, text mining | PubMed |
| Integrating analysis of multi-omics summary data identifies novel plasma protein biomarkers and drug targets for bladder cancer. | Discov Oncol | 2025 | 40316856 | PubTator, text mining | PubMed |
| A Novel Homozygous Nonsense Mutation in TACSTD2 Gene Causes Gelatinous Drop-like Corneal Dystrophy in a Chinese Consanguineous Family: A Case Report and Literature Review. | Cornea | 2025 | 40315281 | PubTator, text mining | PubMed |
| Chimeric antigen receptor NK cells for breast cancer immunotherapy. | Cancer Treat Rev | 2025 | 40305951 | PubTator, text mining | PubMed |
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer. | Ther Adv Med Oncol | 2025 | 40297626 | PubTator, text mining | PubMed |
| Pretargeting: Bridging the Two Worlds of Radiopharmaceutical Probes. | Clin Cancer Res | 2025 | 40293376 | PubTator, text mining | PubMed |
| Therapeutic Potential of Datopotamab Deruxtecan in the Treatment of Advanced Non-Small Cell Lung Cancer: Evidence to Date. | Onco Targets Ther | 2025 | 40291609 | PubTator, text mining | PubMed |
| InSituCor: exploring spatially correlated genes conditional on the cell type landscape. | Genome Biol | 2025 | 40275395 | PubTator, text mining | PubMed |
| [Diffuse interstitial lung disease induced by antibody-drug conjugates]. | Rev Mal Respir | 2025 | 40263022 | PubTator, text mining | PubMed |
| Antibody-Based Therapeutics in Small Cell Lung Cancer: A Narrative Review. | Biologics | 2025 | 40260055 | PubTator, text mining | PubMed |
| Evaluation of Nectin-4 and Trop-2: Implications for Patient Outcomes and Therapy in Penile Cancer. | Mod Pathol | 2025 | 40252843 | PubTator, text mining | PubMed |
| Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution. | Curr Oncol Rep | 2025 | 40238068 | PubTator, text mining | PubMed |
| Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates. | bioRxiv | 2025 | 40235972 | PubTator, text mining | PubMed |
| Trop-2 expression in non-small cell lung cancer. | PLoS One | 2025 | 40233061 | PubTator, text mining | PubMed |
| Mapping the patent landscape of TROP2-targeted biologics through deep learning. | Nat Biotechnol | 2025 | 40229366 | PubTator, text mining | PubMed |
| FDA approves Datroway: a novel therapy for HR-positive, HER2-negative metastatic breast cancer. | Ann Med Surg (Lond) | 2025 | 40212175 | PubTator, text mining | PubMed |
| Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials. | Nat Med | 2025 | 40210967 | PubTator, text mining | PubMed |
| Trop2-expression in primary vulvar squamous cell carcinoma. | Gynecol Oncol | 2025 | 40184712 | PubTator, text mining | PubMed |
| Safety and Tolerability of Concurrent Radiotherapy and Sacituzumab Govitecan in Metastatic Breast Cancer. | Am J Clin Oncol | 2025 | 40178882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=30